glp 1 for diabetes type 2 GLP-1 receptor agonists are increasingly used to treat and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal. Read Quiz: Do You Know Enough

(HIV)

Longer-term benefits may include enhanced immune function and improved overall health , and these can be maintained with regular IV sessions as recommended by healthcare providers

This cellular priming provides the mechanistic foundation for FOXO4-DRI's selective targeting, enabling researchers to eliminate senescent cells without affecting healthy tissue function

FranceschiCCapriMMontiDGiuntaSOlivieriFSeviniFet alInflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans

Oral alternatives Oral GLP-1 formulations are emerging as alternatives to injection

Activity One of our physicians, Jean Liew, MD is actively involved in research on ankylosing spondylitis and associated cardiovascular disease